Skip to content
10-Q

Quarterly Report

10x Genomics, Inc. TXG

0001628280-25-050332

← back to feed
Filed
Nov 7, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q3 2025 · Sep 30, 2025 125.5M sh
Shares Diluted Q3 2025 · Sep 30, 2025 123.97M sh
Shares Diluted Q3 2025 · Sep 30, 2024 120.73M sh
Shares Diluted Q3 2025 · Sep 30, 2024 120.07M sh
Capex Q3 2025 · Sep 30, 2025 $4.16M
Capex Q3 2025 · Sep 30, 2024 $9.68M
Operating Cash Flow Q3 2025 · Sep 30, 2025 $95.27M
Operating Cash Flow Q3 2025 · Sep 30, 2024 $13.41M
Stockholders Equity Q3 2025 · Sep 30, 2025 $785.12M
Stockholders Equity Q3 2025 · Jun 30, 2025 $773.28M
Stockholders Equity Q3 2025 · Mar 31, 2025 $706.9M
Stockholders Equity Q3 2025 · Dec 31, 2024 $710.13M
Stockholders Equity Q3 2025 · Sep 30, 2024 $722.8M
Stockholders Equity Q3 2025 · Jun 30, 2024 $724.06M
Stockholders Equity Q3 2025 · Mar 31, 2024 $718.83M
Stockholders Equity Q3 2025 · Dec 31, 2023 $741.04M
Current Liabilities Q3 2025 · Sep 30, 2025 $147.32M
Current Liabilities Q3 2025 · Dec 31, 2024 $117.63M
Total Liabilities Q3 2025 · Sep 30, 2025 $242.24M
Total Liabilities Q3 2025 · Dec 31, 2024 $208.5M
Current Assets Q3 2025 · Sep 30, 2025 $659.83M
Current Assets Q3 2025 · Dec 31, 2024 $584.39M
Total Assets Q3 2025 · Sep 30, 2025 $1.03B
Total Assets Q3 2025 · Dec 31, 2024 $918.64M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.22
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.22
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.30
Eps Diluted Q3 2025 · Sep 30, 2024 −$1.11
Eps Basic Q3 2025 · Sep 30, 2025 −$0.22
Eps Basic Q3 2025 · Sep 30, 2025 −$0.22
Eps Basic Q3 2025 · Sep 30, 2024 −$0.30
Eps Basic Q3 2025 · Sep 30, 2024 −$1.11
Sga Expense Q3 2025 · Sep 30, 2025 $75.36M
Sga Expense Q3 2025 · Sep 30, 2025 $239.52M
Sga Expense Q3 2025 · Sep 30, 2024 $81.7M
Sga Expense Q3 2025 · Sep 30, 2024 $250.52M
Net Income Q3 2025 · Sep 30, 2025 −$27.47M
Net Income Q3 2025 · Sep 30, 2025 −$27.29M
Net Income Q3 2025 · Jun 30, 2025 $34.54M
Net Income Q3 2025 · Mar 31, 2025 −$34.36M
Net Income Q3 2025 · Sep 30, 2024 −$35.75M
Net Income Q3 2025 · Sep 30, 2024 −$133.6M
Net Income Q3 2025 · Jun 30, 2024 −$37.9M
Net Income Q3 2025 · Mar 31, 2024 −$59.95M
Operating Income Q3 2025 · Sep 30, 2025 −$32.24M
Operating Income Q3 2025 · Sep 30, 2025 −$41.44M
Operating Income Q3 2025 · Sep 30, 2024 −$41.49M
Operating Income Q3 2025 · Sep 30, 2024 −$144.72M
Gross Profit Q3 2025 · Sep 30, 2025 $100.31M
Gross Profit Q3 2025 · Sep 30, 2025 $330.84M
Gross Profit Q3 2025 · Sep 30, 2024 $106.39M
Gross Profit Q3 2025 · Sep 30, 2024 $303.53M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $48.7M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $145.96M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $45.26M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $142.24M
Revenue Q3 2025 · Sep 30, 2025 $149M
Revenue Q3 2025 · Sep 30, 2025 $476.79M
Revenue Q3 2025 · Sep 30, 2024 $151.65M
Revenue Q3 2025 · Sep 30, 2024 $445.76M